Gary O. Rankin, Ph.D., West Virginia Clinical and Translational Science Institute associate director and pilot projects core director was recently named the winner of the 2019 Career Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET) Division of Toxicology.
Rankin received this award at the recent ASPET Annual Meeting held in Orlando, Florida. This award was given in recognition of Rankin’s extensive track record of scholarship in the field of nephrotoxicity as well as his leadership and mentorship in toxicology.
Rankin has served as WVCTSI associate director and director of the pilot projects core since 2017, providing invaluable strategic guidance and building a strong pilot projects program.
“It is truly an honor to be recognized with this award, not only for our work in the field of renal toxicology, but also for leadership and mentoring,” said Rankin. “Mentoring the next generation of West Virginia scientists has always been very important to me.”
This dedication to mentoring, scholarship, and leadership is one of Dr. Rankin’s greatest strengths according to WVCTSI director Sally Hodder, M.D.
“WVCTSI is able to function at such a high level and fulfil our mission of bringing impactful research to our state due in no small part to the leadership of Dr. Rankin,” said Hodder. “From reviewing pilot applications, mentoring junior investigators, and much more, WVCTSI is enhanced by his conscientious efforts and dedication.”
WVCTSI Background
WVCTSI is funded by an IDeA Clinical and Translational grant from the National Institute of General Medical Sciences (5U54GM104942-03) to support the mission of building clinical and translational research infrastructure and capacity to impact health disparities in West Virginia.
-WVCTSI-
CONTACT:
Ian Moore
West Virginia Clinical and Translational Science Institute
304.581.1781